SIM
KYNB

Spark Investment Management’s Kyntra Bio KYNB Stock Holding History

Spark Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,700
Closed -$4.75M – 796
2017
Q1 		$4.75M Buy
7,700
+4,216
+121% +$2.57M 0.3% 86
2016
Q4 		$1.86M Buy
3,484
+1,792
+106% +$895K 0.15% 211
2016
Q3 		$875K Hold
1,692
– – 0.07% 380
2016
Q2 		$694K Buy
+1,692
New +$775K 0.06% 387

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Spark Investment Management's KYNB Position: Q2 2017 in Review

Spark Investment Management sold out of Kyntra Bio (KYNB) in Q2 2017, closing a stake of 7,700 shares — an estimated $4.75M sold.

Spark Investment Management first reported a position in KYNB in Q2 2016 and held it in 4 quarters. The position peaked at $4.75M in Q1 2017. 151 funds tracked by Wall St. Rank hold KYNB as of Q2 2017.

  • Spark Investment Management reported no remaining Kyntra Bio position as of Q2 2017 after selling out during the quarter.
  • Spark Investment Management sold 7,700 Kyntra Bio shares in Q2 2017, an estimated $4.75M.
  • Spark Investment Management first reported a position in Kyntra Bio in Q2 2016 and held it in 4 quarters.
  • Spark Investment Management's Kyntra Bio position peaked at $4.75M in Q1 2017.
  • 151 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2017.

Based on Spark Investment Management's 13F filing for Q2 2017, filed 27 Jul 2017.